Status:
COMPLETED
Behavior Change and Digital Health Interventions for Improved TB Treatment Outcomes
Lead Sponsor:
Massachusetts Institute of Technology
Collaborating Sponsors:
Keheala
United States Agency for International Development (USAID)
Conditions:
Tuberculosis
Adherence, Patient
Eligibility:
All Genders
Phase:
NA
Brief Summary
Each year, 10.4 million patients are diagnosed with and 1.7 million people die from Tuberculosis (TB). Despite the availability of highly effective and accessible medications in the developing world w...
Detailed Description
Tuberculosis (TB) is the world's deadliest infectious disease. Each year, 10.4 million new individuals are diagnosed with TB, and 1.7 million are killed. Despite the availability of highly effective m...
Eligibility Criteria
Inclusion
- To be eligible for the study, subjects must:
- be either clinically diagnosed or bacteriologically confirmed to have TB, MDR TB or EP TB.
- communicate in either Swahili or English.
- have access to a mobile phone (shared or owned).
- have at least two months of treatment remaining.
- Exclusion Criteria:
- \- subjects who do not consent to participate.
- Note that subjects are randomized into intervention groups or the control group after providing consent.
- Subjects who are enrolled but are found, retrospectively to not meet the criteria (i.e. they had less than two months remaining when they were enrolled) will be monitored as part of a, fifth "non-eligible" group, and will not count towards the enrollment targets.
Exclusion
Key Trial Info
Start Date :
April 13 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2021
Estimated Enrollment :
16146 Patients enrolled
Trial Details
Trial ID
NCT04119375
Start Date
April 13 2018
End Date
July 30 2021
Last Update
January 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kenya National TB Program
Nairobi, Kenya